1. Home
  2. BDSX vs TAYD Comparison

BDSX vs TAYD Comparison

Compare BDSX & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • TAYD
  • Stock Information
  • Founded
  • BDSX 2005
  • TAYD 1955
  • Country
  • BDSX United States
  • TAYD United States
  • Employees
  • BDSX N/A
  • TAYD N/A
  • Industry
  • BDSX Precision Instruments
  • TAYD Industrial Machinery/Components
  • Sector
  • BDSX Health Care
  • TAYD Industrials
  • Exchange
  • BDSX Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • BDSX 115.4M
  • TAYD 96.0M
  • IPO Year
  • BDSX 2020
  • TAYD N/A
  • Fundamental
  • Price
  • BDSX $0.35
  • TAYD $36.95
  • Analyst Decision
  • BDSX Strong Buy
  • TAYD
  • Analyst Count
  • BDSX 4
  • TAYD 0
  • Target Price
  • BDSX $2.83
  • TAYD N/A
  • AVG Volume (30 Days)
  • BDSX 523.2K
  • TAYD 19.2K
  • Earning Date
  • BDSX 05-13-2025
  • TAYD 03-28-2025
  • Dividend Yield
  • BDSX N/A
  • TAYD N/A
  • EPS Growth
  • BDSX N/A
  • TAYD 1.48
  • EPS
  • BDSX N/A
  • TAYD 2.50
  • Revenue
  • BDSX $71,323,000.00
  • TAYD $42,796,782.00
  • Revenue This Year
  • BDSX $32.90
  • TAYD N/A
  • Revenue Next Year
  • BDSX $24.65
  • TAYD N/A
  • P/E Ratio
  • BDSX N/A
  • TAYD $14.00
  • Revenue Growth
  • BDSX 45.30
  • TAYD N/A
  • 52 Week Low
  • BDSX $0.45
  • TAYD $29.50
  • 52 Week High
  • BDSX $2.04
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 27.69
  • TAYD 70.42
  • Support Level
  • BDSX $0.51
  • TAYD $30.53
  • Resistance Level
  • BDSX $0.58
  • TAYD $35.59
  • Average True Range (ATR)
  • BDSX 0.06
  • TAYD 1.44
  • MACD
  • BDSX -0.01
  • TAYD 0.60
  • Stochastic Oscillator
  • BDSX 1.15
  • TAYD 87.38

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: